Co. Website., page-20

Strong possibility. Funny if it plays out in that it appears Abbvie have funded its development and Amgen pop in to sweep it away

I am guessing but i am hazarding a guess this is likely enough to make me.ponder buying some shares....my problem is what does it really means for UNS?

Do they sell it to Amgen? Do they give them exclusivity and use Flex/CMO to manufacture and supply to Amgen....what are the volumes likely to be? What business model will Amgen adopt: give to patients or make them buy them?

Either way not sure any model really helps UNS a whole lot from here until they can start to show solid basis for 5-7million per qtr earnings which us enough of a platform to tread water from and grow.